Do cannabis dispensary staff receive sufficient training?

December 09, 2016

New Rochelle, NY, Dec. 9, 2016--As legalization of cannabis for medical use increases across the U.S., the training of dispensary staff, who may recommend cannabis type and concentration to patients, requires closer examination. A new study, which found that only 55% of dispensary staff reported having some formal training for their positions, is published in Cannabis and Cannabinoid Research, a new peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Cannabis and Cannabinoid Research website.

In the article "Training and Practices of Cannabis Dispensary Staff ," it was found that only 20% of staff had any medical or scientific training, even though most (94%) reported giving advice to patients. Nancy Haug, PhD, Palo Alto University and Stanford University School of Medicine (Stanford, CA), and coauthors from VA Palo Alto Healthcare System, Johns Hopkins University School of Medicine (Baltimore, MD), Philadelphia Veteran's Administration Medical Center (PA), and University of Pennsylvania Perelman School of Medicine (Philadelphia), report that some of the cannabis recommendations made by dispensary staff have not been shown to be effective and could even cause a patient's condition to worsen.

"These numbers are appalling, but unfortunately not surprising," says Editor-in-Chief Daniele Piomelli, PhD, University of California-Irvine, School of Medicine. "Establishing training guidelines and programs for dispensary staff has clearly become an urgent national priority."
-end-
About the Journal

Cannabis and Cannabinoid Research is the only peer-reviewed open access journal dedicated to the scientific, medical, and psychosociall exploration of clinical cannabis, cannabinoids, and the biochemical mechanisms of endocannabinoids. Led by Editor-in-Chief Daniele Piomelli, PhD, the Journal publishes a broad range of human and animal studies including basic and translational research; clinical studies; behavioral, social, and epidemiological issues; and ethical, legal, and regulatory controversies. Complete information is available on the Cannabis and Cannabinoid Research website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Journal of Medicinal Food, The Journal of Alternative and Complementary Medicine, and Journal of Child and Adolescent Psychopharmacology. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers) website.

Mary Ann Liebert, Inc./Genetic Engineering News

Related Cannabis Articles from Brightsurf:

Cannabis to treat gynecological conditions
A significant number of women would consider using cannabis to treat gynecological conditions, primarily gynecological pain.

Cannabis data lacking, but machine learning could help
Everyone's heard of THC and CBD. But many other active compounds in cannabis interact to influence its effects.

Cannabis use for menopause symptom management
CLEVELAND, Ohio (September 28, 2020)--As legislation relaxes regarding cannabis, it is being used to manage numerous chronic health conditions and mood symptoms.

Prescribed CBD could help people quit cannabis
A benchmark clinical trial published today shows that cannabidiol (CBD) could be a safe and effective treatment for problematic cannabis use.

Pregnant women with depression are more than 3 times more likely to use cannabis
Cannabis use is much more common among pregnant women with depression and pregnant women with depression are more than 3 times more likely to use cannabis than those without depression.

Cannabis compound acts as an antibiotic 
Public health agencies worldwide have identified antibiotic resistance of disease-causing bacteria as one of humanity's most critical challenges.

Cannabis use during pregnancy
The large health care system Kaiser Permanente Northern California provides universal screening for prenatal cannabis use in women during pregnancy by self-report and urine toxicology testing.

Questions and answers about cannabis use during pregnancy
A new study shows that women have many medical questions about the use of cannabis both before and during pregnancy, and during the postpartum period while breastfeeding.

Managing cannabis use in breastfeeding women
As more states legalize medicinal and recreational cannabis use and increasingly decriminalize cannabis, the risk to the growth and development of breastfeeding infants whose mothers use cannabis becomes a growing public health concern.

Cannabis edibles present novel health risks
With the recent legalization of cannabis edibles in Canada, physicians and the public must be aware of the novel risks of cannabis edibles, argue authors in a commentary in CMAJ (Canadian Medical Association Journal).

Read More: Cannabis News and Cannabis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.